Plain-English translation of NCT07106294 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Preeclampsia is a serious pregnancy condition that develops when blood pressure rises and organs are affected. This study is testing whether hyperspectral imaging—a special camera that takes detailed pictures of blood flow in the skin—can spot early warning signs of preeclampsia before symptoms appear. If successful, this imaging could help doctors identify pregnant women at highest risk and provide earlier, personalized care.
Preeclampsia can be life-threatening for both mother and baby, and it often develops suddenly. Currently, doctors don't have an easy way to predict who will develop it early enough to prevent serious complications. This new imaging technique could fill that gap by catching the disease's earliest changes in blood vessels before symptoms occur.
You likely qualify if…
You likely don't qualify if…
You would have the special imaging scan performed during your regular pregnancy ultrasound visit—either in the first trimester (around weeks 11–14) or second trimester (around weeks 18–22). The imaging itself is non-invasive and contactless, meaning nothing touches your skin; it works like a camera taking detailed pictures of your blood flow. The study team will follow your pregnancy to see if any participants develop preeclampsia and compare their imaging results to those who do not.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Germany